Yanping Xu

9PUBLICATIONS
29CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Molecular targetsChemical engineering designCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 25, 2026
AKT1 phosphorylates PRMT7 to promote GLUD1 methylation and gastric cancer progression.

Ziyi Cui, Hongchen Li, Xiaoben Liang

|Aug 07, 2023
TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential.

Jing He, Mingen Lin, Xinchao Zhang

|Mar 08, 2022
Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses.

Lei-Lei Chen, Carmen Morcelle, Zhou-Li Cheng

|Feb 19, 2022
D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1.

Ruonan Zhang, Yajing Yang, Wenjing Dong

Pageof 2